MediciNova (MNOV) is scheduled to report Q1 earnings on May 29, 2026. Analysts estimate EPS of $-0.06 and quarterly revenue of N/A.
In the most recent quarter (Q4), MediciNova reported EPS of $-0.05, beating estimates of $-0.08 by 0.38%. Revenue came in at $151.74K, exceeding the estimate of $0.00 by 0.00%.
MediciNova has beaten EPS estimates in 4 consecutive quarters.
Over the last 4 quarters, MediciNova has averaged an EPS surprise of 0.43% and a revenue surprise of 0.00%.
Analyze the earnings history of MediciNova using advanced sorting and filters.
The chart below shows MediciNova's reported EPS compared to analyst estimates over recent quarters.
The chart below shows MediciNova's reported revenue compared to analyst estimates over recent quarters.
MediciNova (MNOV) is scheduled to report earnings on August 13, 2026. The last reported earnings were for reported on February 20, 2026 for Q4.
The Actual EPS was $-0.05, which beat the estimate of $-0.08.
The Actual Revenue was $151.74K, which beat the estimate of $0.00.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2026-02-20 | $-0.05 | $-0.08 | 37.5 % |
| Q3 | 2025-11-12 | $-0.06 | $-0.11 | 45.5 % |
| Q2 | 2025-08-14 | $-0.07 | $-0.10 | 30.0 % |
| Q1 | 2025-05-13 | $-0.06 | $-0.14 | 57.1 % |